Award
NIH Reporter #5R50CA293837-04
Investigating epigenetic mechanisms of cancer
Recipient
VAN ANDEL RESEARCH INSTITUTE
Award Amount
$204,106.00
Ceiling
$204,106.00
Awarded
September 17, 2026
Identifier
5R50CA293837-04
Research grant awarded by the National Cancer Institute to VAN ANDEL RESEARCH INSTITUTE for studying epigenetic mechanisms of cancer, funded at $204,106 for the period 2024-2029.
Description
This is a research grant award from the National Cancer Institute for investigating epigenetic mechanisms of cancer, with a focus on histone mutations, chromatin dynamics, and therapy resistance. The project involves multiple techniques including biochemical assays, gene expression analysis, chromatin profiling, and CRISPR screens. The award supports a project period from September 2024 to August 2029, with a total funding of $204,106 for fiscal year 2026.